Abzu

Abzu

Forskning inden for bioteknologi

Nordhavn, Capital Region 4.530 følgere

Abzu is the best in class in silico disease understanding and drug design company.

Om os

Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D. Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.

Websted
http://abzu.ai
Branche
Forskning inden for bioteknologi
Virksomhedsstørrelse
11-50 medarbejdere
Hovedkvarter
Nordhavn, Capital Region
Type
Privat
Grundlagt
2018
Specialer
RNA Therapeutics, RNA Tx, AI, artificial intelligence, explainable AI, trustworthy AI, QLattice, drug development, pharma og pharma R&D

Beliggenheder

  • Primær

    Orient Plads 1

    Mezzanine

    Nordhavn, Capital Region 2150, DK

    Se ruten
  • c/o Carrer d’Àlaba

    100

    Barcelona, 08018, ES

    Se ruten

Medarbejdere hos Abzu

Opdateringer

Tilsvarende sider

Finansiering

Abzu 5 runder i alt

Seneste runde

Giv adgang

2.609.298,00 US$

Læs mere på crunchbase